GR1009978B - Gel for topical application for antisepsis, disinfection and protection against bacteria, viruses and fungi - Google Patents
Gel for topical application for antisepsis, disinfection and protection against bacteria, viruses and fungi Download PDFInfo
- Publication number
- GR1009978B GR1009978B GR20190100567A GR20190100567A GR1009978B GR 1009978 B GR1009978 B GR 1009978B GR 20190100567 A GR20190100567 A GR 20190100567A GR 20190100567 A GR20190100567 A GR 20190100567A GR 1009978 B GR1009978 B GR 1009978B
- Authority
- GR
- Greece
- Prior art keywords
- composition
- present
- agent
- amounts
- gel
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 6
- 241000894006 Bacteria Species 0.000 title abstract description 4
- 241000233866 Fungi Species 0.000 title abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 title description 2
- 230000000699 topical effect Effects 0.000 title description 2
- 230000003260 anti-sepsis Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 238000009472 formulation Methods 0.000 claims abstract description 7
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 6
- 230000003253 viricidal effect Effects 0.000 claims abstract description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 208000000474 Poliomyelitis Diseases 0.000 claims description 3
- 230000003113 alkalizing effect Effects 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 235000019441 ethanol Nutrition 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 230000035699 permeability Effects 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- 239000011703 D-panthenol Substances 0.000 claims 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims 1
- 235000004866 D-panthenol Nutrition 0.000 claims 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims 1
- 125000005250 alkyl acrylate group Chemical group 0.000 claims 1
- 229920006037 cross link polymer Polymers 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 claims 1
- 229960003949 dexpanthenol Drugs 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 claims 1
- 229960000368 sulisobenzone Drugs 0.000 claims 1
- 241000991587 Enterovirus C Species 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 241000228245 Aspergillus niger Species 0.000 abstract description 2
- 241000222122 Candida albicans Species 0.000 abstract description 2
- 241001500351 Influenzavirus A Species 0.000 abstract description 2
- 241001500350 Influenzavirus B Species 0.000 abstract description 2
- 241001105894 Murine norovirus Species 0.000 abstract description 2
- 108010003533 Viral Envelope Proteins Proteins 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 229940095731 candida albicans Drugs 0.000 abstract description 2
- 241001493065 dsRNA viruses Species 0.000 abstract description 2
- 230000000855 fungicidal effect Effects 0.000 abstract description 2
- 210000004779 membrane envelope Anatomy 0.000 abstract description 2
- 230000003472 neutralizing effect Effects 0.000 abstract description 2
- 241000701161 unidentified adenovirus Species 0.000 abstract description 2
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
ΠΕΡΙΓΡΑΦΗ DESCRIPTION
ΣΚΕΥΑΣΜΑ (ΓΕΛΗ) ΤΟΠΙΚΗΣ ΕΦΑΡΜΟΓΗΣ ΓΙΑ ΑΝΤΙΣΗΨΙΑ, ΑΠΟΛΥΜΑΝΣΗ ΚΑΙ PREPARATION (GEL) FOR TOPICAL APPLICATION FOR ANTISEPTIC, DISINFECTING AND
ΠΡΟΣΤΑΣΙΑ ΑΠΟ ΙΟΥΣ, ΒΑΚΤΗΡΙΑ, ΜΥΚΗΤΕΣ. PROTECTION AGAINST VIRUSES, BACTERIA, FUNGI.
Η εφεύρεση αφορά ένα μη εκπλενόμενο σκεύασμα τοπικής εφαρμογής (γέλη) για αντισηψία και απολύμανση δέρματος με ταυτόχρονη ιοκτόνο, βακτηριοκτόνο και μυκητοκτόνο δράση. Το προϊόν εφαρμόζεται στο δέρμα και ασκεί αντισηπτική δράση εξουδετερώνοντας ταυτόχρονα α) ιούς των κατηγοριών: POLIOVIRUS, MURINE NOROVIRUS, INFLUENZA VIRUS A, INFLUENZA VIRUS B, ADENOVIRUS, β) τα βακτήρια: PSEUDOMONAS AERUGINOSA, ESCHERICHIA COLI, STAPHYLOCOCCOUS AUREOUS, ENTEROCOCCOUS HIRAE και γ) τους μύκητες: CANDIDA ALBICANS, ASPERGILLUS NIGER (BRASILIENSIS). Επιπλέον ασκεί ενυδατική και μαλακτική δράση επί του δέρματος. Η σύσταση του σκευάσματος περιλαμβάνει μίγμα ισοπροπυλικής αλκοόλης καθαρότητας περίπου 100% και αιθυλικής αλκοόλης καθαρότητας 96% σε κατάλληλο φορέα. Το σκεύασμα είναι κατάλληλο και ασφαλές για πολλές εφαρμογές ημερησίως και για μακροχρόνια χρήση στο δέρμα και διατηρεί τη χημική και φυσική του σταθερότητα κατά την αποθήκευση, για μεγάλο χρονικά διάστημα, αλλά και για όσο διαρκεί η χρήση του. Η χρήση του εν λόγω σκευάσματος πλεονεκτεί έναντι άλλων αντίστοιχων προϊόντων λόγω της ιδιαίτερα αποτελεσματικής ιοκτάνου δράσης του κατά της ομάδας των ιών της πολιομυελίτιδας (POLIO), οι οποίοι ως RNA ιοί δεν έχουν ιϊκό περίβλημα γεγονός που τους καθιστά άτρωτους στις διάφορες ευρέως χρησιμοποιούμενες ιοκτάνες ουσίες. The invention relates to a non-rinsable preparation for local application (gel) for antiseptic and skin disinfection with simultaneous virucidal, bactericidal and fungicidal action. The product is applied to the skin and exerts an antiseptic effect by simultaneously neutralizing a) viruses of the categories: POLIOVIRUS, MURINE NOROVIRUS, INFLUENZA VIRUS A, INFLUENZA VIRUS B, ADENOVIRUS, b) bacteria: PSEUDOMONAS AERUGINOSA, ESCHERICHIA COLI, STAPHYLOCOCCOUS AUREOUS, ENTEROCOCCOUS HIRAE and c ) the fungi: CANDIDA ALBICANS, ASPERGILLUS NIGER (BRASILIENSIS). In addition, it has a moisturizing and softening effect on the skin. The composition of the formulation includes a mixture of isopropyl alcohol of approximately 100% purity and ethyl alcohol of 96% purity in a suitable carrier. The formulation is suitable and safe for multiple applications daily and for long-term use on the skin and maintains its chemical and physical stability during storage, for a long period of time, and for as long as its use lasts. The use of this preparation is advantageous over other corresponding products due to its particularly effective virulent action against the group of poliomyelitis viruses (POLIO), which as RNA viruses do not have a viral envelope, which makes them invulnerable to the various widely used virulent substances.
Η σύνθεση της παρούσας εφεύρεσης αποτελείται από έναν φορέα και από το μίγμα των δραστικών ουσιών. Ο φορέας της σύνθεσης της παρούσας εφεύρεσης αποτελείται από εξευγενισμένο ύδωρ, έναν παράγοντα σχηματισμού γέλης, έναν παράγοντα αλκαλοποίησης, έναν παράγοντα επιτάχυνσης διαπερατότητας, έναν μαλακτικά παράγοντα, έναν χρωστικά παράγοντα και έναν παράγοντα σταθεροποίησης χρώματος, όλοι σε ποσοστά 0,001 έως 80,000 % β.κ.β. και κατά προτίμηση σε ποσοστά 0,001 έως 40,000 % β.κ.β. The composition of the present invention consists of a carrier and the mixture of active substances. The carrier of the composition of the present invention consists of purified water, a gelling agent, an alkalizing agent, a permeability accelerating agent, a softening agent, a coloring agent, and a color stabilizing agent, all in amounts of 0.001 to 80,000 wt.%. b. and preferably in amounts of 0.001 to 40,000 wt.%.
Οι δραστικές ουσίες του σκευάσματος είναι σε ποσοστά 0,001 έως 99,999 % β.κ.β. και κατά προτίμηση, σε ποσοστά 0,001 έως 90,000 % β.κ.β. The active substances of the formulation are in percentages of 0.001 to 99.999 % b.w. and preferably, in amounts of 0.001 to 90,000 wt.%.
To pH της σύνθεσης της παρούσας εφεύρεσης ρυθμίζεται σε εύρος από περίπου 4,00 έως περίπου 9,00 με: α) αμιγή οξέα ή διαλύματα αυτών, όπως το υδροχλωρικά οξύ, το γαλακτικά οξύ, το θειϊκό οξύ, το μεθανικά οξύ, το αιθανικά οξύ, ή ρυθμίζεται β) αμιγείς βάσεις ή διαλύματα αυτών όπως το υδροξειδίο του νατρίου, το υδροξειδίο του καλιού, το υδροξειδίο του βαρίου, η τριαιθανολαμίνη, η αμμωνία, οι διάφορες αμίνες, γ) με αμιγή ουδέτερα ή όξινα ανθρακικά άλατα ή διαλύματα αυτών όπως το ανθρακικά νάτριο, το όξινο ανθρακικά νάτριο, το ανθρακικά κάλιο, το όξινο ανθρακικά κάλιο. The pH of the composition of the present invention is adjusted in a range from about 4.00 to about 9.00 with: a) pure acids or solutions thereof, such as hydrochloric acid, lactic acid, sulfuric acid, methanoic acid, ethanoic acid , or adjusted b) pure bases or solutions thereof such as sodium hydroxide, potassium hydroxide, barium hydroxide, triethanolamine, ammonia, various amines, c) with pure neutral or acidic carbonates or solutions thereof such as sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate.
Αν και το σκεύασμα είναι αποτελεσματικά με μία μόνο χρήση για αρκετές ώρες, για την επίτευξη των στόχων της λειτουργίας του σκευάσματος της παρούσας εφεύρεσης, η ενδεικνυάμενη εφαρμογή είναι όσες φορές ημερησίως επιθυμεί ο χρήστης και για μεγάλη χρονική περίοδο. Σε κάθε περίπτωση, αν και το σκεύασμα απομακρύνεται δύσκολα από το δέρμα με έκπλυση με νερά, συνίσταται η μη έκπλυση του δέρματος μετά την εφαρμογή. Although the formulation is effective with a single use for several hours, to achieve the goals of the formulation of the present invention, the indicated application is as many times a day as the user wishes and for a long period of time. In any case, although the preparation is difficult to remove from the skin by rinsing with water, it is recommended not to rinse the skin after application.
Τα ακόλουθα παραδείγματα δίδονται προκειμένου να απεικονιστεί η εφεύρεση και δεν περιορίζουν κατά κανένα τρόπο το εύρος των αξιώσεων. The following examples are given to illustrate the invention and do not in any way limit the scope of the claims.
Παραδείγματα Examples
Παρασκευάστηκαν δοκίμια με τις εξής σ υστάσεις: Tests were prepared with the following recommendations:
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20190100567A GR1009978B (en) | 2019-12-20 | 2019-12-20 | Gel for topical application for antisepsis, disinfection and protection against bacteria, viruses and fungi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20190100567A GR1009978B (en) | 2019-12-20 | 2019-12-20 | Gel for topical application for antisepsis, disinfection and protection against bacteria, viruses and fungi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1009978B true GR1009978B (en) | 2021-04-22 |
Family
ID=76034324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20190100567A GR1009978B (en) | 2019-12-20 | 2019-12-20 | Gel for topical application for antisepsis, disinfection and protection against bacteria, viruses and fungi |
Country Status (1)
| Country | Link |
|---|---|
| GR (1) | GR1009978B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2127520A1 (en) * | 2006-11-15 | 2009-12-02 | Maruishi Pharmaceutical Co., Ltd. | Gel-like sterilizing/disinfecting composition |
| US20120208894A1 (en) * | 2008-03-17 | 2012-08-16 | Bode Chemie Gmbh & Co. Kg | Multi-purpose hand disinfectant |
| US20140364509A1 (en) * | 2013-06-06 | 2014-12-11 | Ecolab Usa Inc. | Alcohol based sanitizer with improved dermal compatibility and feel |
| US20180140539A1 (en) * | 2016-11-23 | 2018-05-24 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| US20180256462A1 (en) * | 2015-09-30 | 2018-09-13 | Deb Ip Limited | Alcohol-based skin sanitizer having microbicidal properties |
-
2019
- 2019-12-20 GR GR20190100567A patent/GR1009978B/en active IP Right Grant
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2127520A1 (en) * | 2006-11-15 | 2009-12-02 | Maruishi Pharmaceutical Co., Ltd. | Gel-like sterilizing/disinfecting composition |
| US20120208894A1 (en) * | 2008-03-17 | 2012-08-16 | Bode Chemie Gmbh & Co. Kg | Multi-purpose hand disinfectant |
| US20140364509A1 (en) * | 2013-06-06 | 2014-12-11 | Ecolab Usa Inc. | Alcohol based sanitizer with improved dermal compatibility and feel |
| US20180256462A1 (en) * | 2015-09-30 | 2018-09-13 | Deb Ip Limited | Alcohol-based skin sanitizer having microbicidal properties |
| US20180140539A1 (en) * | 2016-11-23 | 2018-05-24 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020207849B2 (en) | Compositions and methods with efficacy against spores and other organisms | |
| JP2017517484A5 (en) | ||
| RU2011132893A (en) | DISINFECTANT | |
| JPS6314702A (en) | Virucide with broad area effect | |
| NZ550744A (en) | Hydrogen peroxide-based skin disinfectant | |
| FR2552305A1 (en) | HIGH BACTERICIDAL COMPOSITION CONTAINING BIGUANIDE AND PYRIMIDINE | |
| TW201615179A (en) | Mouthwash composition | |
| US9936695B1 (en) | Compositions and methods having improved efficacy against spores and other organisms | |
| Nasila et al. | A review on cetylpyridinium chloride | |
| GR1009978B (en) | Gel for topical application for antisepsis, disinfection and protection against bacteria, viruses and fungi | |
| US10813357B1 (en) | Compositions and methods with efficacy against spores and other organisms | |
| TR200101433T2 (en) | The use of phosphonoformic acid derivatives in the treatment of infections. | |
| CN104523667A (en) | Combination technology for composite quaternary ammonium salt skin mucosa disinfectant | |
| ES2229160T3 (en) | ANTISEPTICO FOR WOUNDS AND MUCOUS MEMBRANES. | |
| CN101972217B (en) | Chlorine dioxide disinfectant oral spray and preparation method thereof | |
| JP2017078029A (en) | Sterilization method and sterilization composition | |
| CN109362768A (en) | A kind of disinfection containing mineral salt is spraying | |
| ES2373948T3 (en) | COMBINATIONS OF MICROBICIDE ACTIVE PRINCIPLES AND DISINFECTING AGENTS PREPARED FROM THE SAME. | |
| CN115474609B (en) | Disinfectant, preparation method thereof and film layer | |
| CN110463721A (en) | A kind of antiseptic sterilization agent and preparation method thereof based on hydrogen peroxide | |
| CN112716822A (en) | Disinfectant for resisting new coronavirus and preparation method thereof | |
| WO2019129902A1 (en) | Use of a fungicidal composition as treatment for powdery mildew | |
| CN104509532A (en) | Ionic targeted sterilization intermediate compounding technology | |
| RU2207155C1 (en) | Antiseptic preparation "leonol" | |
| TH2101000146A (en) | The composition of the disinfectant (disinfectant composition) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PG | Patent granted |
Effective date: 20210519 |